A detailed history of Ewa, LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Ewa, LLC holds 50,584 shares of TLSA stock, worth $39,455. This represents 0.02% of its overall portfolio holdings.

Number of Shares
50,584
Previous 51,173 1.15%
Holding current value
$39,455
Previous $46.1 Million 1.51%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$0.81 - $1.45 $477 - $854
-589 Reduced 1.15%
50,584 $46.8 Million
Q2 2024

Jul 24, 2024

SELL
$0.43 - $1.01 $1,774 - $4,168
-4,127 Reduced 7.46%
51,173 $46.1 Million
Q1 2024

May 13, 2024

BUY
$0.42 - $0.61 $4,966 - $7,212
11,824 Added 27.2%
55,300 $34.4 Million
Q4 2023

Feb 05, 2024

BUY
$0.55 - $0.85 $8,252 - $12,753
15,004 Added 52.7%
43,476 $22.9 Million
Q3 2023

Nov 14, 2023

BUY
$0.6 - $0.82 $17,083 - $23,347
28,472 New
28,472 $16.2 Million

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $79.8M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.